Additional Proxy Soliciting Materials (definitive) (defa14a)
April 29 2021 - 4:12PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
(Rule 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities
Exchange Act of 1934 (Amendment No. )
Filed by the Registrant [x]
Filed by a Party other than the Registrant [ ]
Check the appropriate box:
[ ] Preliminary Proxy Statement
[ ] Confidential, for Use of the
Commission Only (as permitted by Rule
14a-6(e)(2))
[ ] Definitive Proxy Statement
[x] Definitive Additional Materials
[ ] Soliciting Material Pursuant to Rule 14a-12
ENDRA LIFE SCIENCES INC.
(Name of Registrant as Specified in its Charter)
(Name of Person(s) Filing Proxy Statement, if Other Than the
Registrant)
Payment of Filing Fee (Check the appropriate box):
[x] No fee required.
[ ] Fee computed on table below per Exchange
Act Rules 14a-6(i)(1) and 0-11.
(1)Title of each class of securities to which transaction applies:
N/A
(2)Aggregate number of securities to which transaction applies:
N/A
(3)Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which
the filing fee is calculated and state how it was determined):
N/A
(4)Proposed maximum aggregate value of
transaction: N/A
(5) Total fee paid: N/A
[ ]Fee paid previously with preliminary materials.
[ ] Check box if any part of the fee is offset as provided by
Exchange Act Rule 0-11(a)(2) and identify the filing for which the
offsetting fee was paid previously. Identify the previous filing by
registration statement number, or the Form or Schedule and the date
of its filing.
(1) Amount
Previously Paid: N/A
(2) Form,
Schedule or Registration Statement No.: N/A
(3) Filing
Party: N/A
(4) Date
Filed: N/A
ENDRA Life Sciences Inc.
|
CONTROL ID:
|
|
REQUEST ID:
|
|
|
IMPORTANT NOTICE
REGARDING THE AVAILABILITY OF PROXY MATERIALS
FOR THE ANNUAL MEETING OF STOCKHOLDERS
|
|
DATE:
|
TUESDAY, JUNE 8, 2021
|
|
TIME:
|
10:00 a.m. EASTERN TIME
|
|
LOCATION:
|
https://agm.issuerdirect.com/ndra
|
|
|
|
HOW TO REQUEST PAPER COPIES OF OUR MATERIALS
|
|
|
|
|
PHONE:
Call toll free
1-866-752-8683
|
FAX:
Send this card to
202-521-3464
|
INTERNET:
https://www.iproxydirect.com/NDRA
and follow the on-screen
instructions.
|
EMAIL:
proxy@iproxydirect.com
Include your Control ID in your email.
|
|
This communication represents a notice
to access a more complete set of proxy materials available to you
on the Internet. We encourage you to access and review all of the
important information contained in the proxy materials before
voting. The proxy statement is available at: https://www.iproxydirect.com/NDRA
|
|
If you want to receive a paper copy of the proxy materials you must
request one. There is no charge to you for requesting a copy. To
facilitate timely delivery please make the request, as instructed
above, before May 25, 2021.
|
|
|
you may enter your voting instructions at:
https://www.iproxydirect.com/NDRA until
11:59 pm eastern time June 7, 2021.
|
|
|
The purposes of this meeting are as follows:
|
|
|
1. to elect five (5)
nominees to the Board of Directors as nominated by the Board of
Directors: Francois Michelon, Louis J. Basenese, Anthony
DiGiandomenico, Michael Harsh and
Alexander Tokman.
2. To
ratify the appointment of RBSM LLP as the Company’s
independent registered public accounting firm for
2021.
3. To
transact such other business as may properly come before the annual
meeting and any adjournments or postponements thereof.
|
|
Pursuant to Securities and Exchange Commission rules, you are
receiving this Notice that the proxy materials for the Annual
Meeting are available on the Internet. Follow the instructions
above to view the materials and vote or request printed
copies.
The board of directors has fixed the close of business on April 22,
2021 as the record date for the determination of stockholders
entitled to receive notice of the Annual Meeting and to vote the
shares of our common stock, par value $0.0001 per share, and series
a convertible preferred stock, par value $0.0001 per share, they
held on that date at the meeting or any postponement or adjournment
of the meeting.
|
The Board of Directors recommends that you vote ‘for’
all proposals above.
|
|
Please note - This is not a Proxy Card - you cannot vote by
returning this card.
|
ENDRA LIFE SCIENCES INC.
SHAREHOLDER
SERVICES
1
Glenwood Avenue Suite 1001
Raleigh
NC 27603
TIME SENSITIVE SHAREHOLDER INFORMATION ENCLOSED
IMPORTANT SHAREHOLDER INFORMATION
YOUR VOTE IS IMPORTANT
ENDRA Life Sciences (NASDAQ:NDRA)
Historical Stock Chart
From Aug 2024 to Sep 2024
ENDRA Life Sciences (NASDAQ:NDRA)
Historical Stock Chart
From Sep 2023 to Sep 2024